Endothelial growth factor receptor inhibition after radiotherapy.
Giovannini
Monica
M
Department of Medical Oncology, San Raffaele Scientific Institute, Milan, Italy. giovannini.monica@hsr.it
Gregorc
Vanesa
V
Viganò
Maria Grazia
MG
Spreafico
Anna
A
Ghio
Domenico
D
Dell'Oca
Italo
I
Bolognesi
Angelo
A
Villa
Eugenio
E
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000037:antagonists & inhibitors / Q000097:blood; D002289:Carcinoma, Non-Small-Cell Lung / Q000097:blood / Q000188:drug therapy / Q000532:radiotherapy; D005500:Follow-Up Studies; D000077156:Gefitinib; D006801:Humans; D008175:Lung Neoplasms / Q000097:blood / Q000188:drug therapy / Q000532:radiotherapy; D008297:Male; D008875:Middle Aged; D011799:Quinazolines / Q000627:therapeutic use*; D011832:Radiation Injuries / Q000188:drug therapy / Q000473:pathology; D040262:Receptors, Vascular Endothelial Growth Factor / Q000037:antagonists & inhibitors* / Q000097:blood; D012867:Skin / Q000473:pathology / Q000528:radiation effects
D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; D011799:Quinazolines; D040262:Receptors, Vascular Endothelial Growth Factor; D000077156:Gefitinib